First four-strain flu vaccine approved
China’s drug regulator has approved the country’s first vaccine that can protect people from four influenza virus strains.
The four-strain vaccine adds protection against the Yamagata lineage of Influenza B, which was the main virus strain during the last flu season, according to the National Drug Administration of China. The vaccine may be used on adults and children aged three years and above. H1N1 and H3N2 of Influenza A, and Victoria and Yamagata lineages of Influenza B are the common strains of human flu viruses. Until now, China had only three-strain vaccines on the market.